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Abstract
Background: The challenge of diagnosing smear-negative pulmonary TB (tuberculosis) in people living with HIV justifies the
use of instruments other than the smear test for diagnosing the disease. Considering the clinical-radiological similarities of
TB amongst HIV-infected adults and children, the proposal of this study was to assess the accuracy of a scoring system used
to diagnose smear-negative pulmonary TB in children and adolescents, in HIV-infected adults suspected of having smear-
negative pulmonary TB.
Methods: A Phase III validation study aiming to assess the diagnostic accuracy of a scoring system for diagnosing smear-
negative pulmonary TB in HIV-infected adults. The study assessed sensitivity, specificity, positive and negative likelihood
ratios, and positive and negative predictive values of the scoring system. Three versions of the scoring system were tested.
Results: From a cohort of 2,382 (HIV-infected adults), 1276 were investigated and 128 were diagnosed with pulmonary TB.
Variables associated with the diagnosis of TB were: coughing, weight loss, fever, malnutrition, chest X-ray, and positive
tuberculin test. The best diagnostic performance occurred with the scoring system with new scores, with sensitivity = 81.2%
(95%-CI 74.5% –88%), specificity = 78% (75.6% –80.4%), PPV= 29.2% (24.5% –33.9%) and NPV= 97.4% (96.4% –98.4%), LR+
= 3.7 (3.4–4.0) and LR2= 0.24 (0.2–0.4).
Conclusion: The proposed scoring system (with new scores) presented a good capacity for discriminating patients who did
not have pulmonary TB, in the studied population. Further studies are necessary in order to validate it, thus permitting the
assessment of its use in diagnosing smear-negative pulmonary TB in HIV-infected adults.
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Introduction
Tuberculosis (TB) is the most frequent cause of death in people
living with HIV (PLHIV) [1], with high mortality in smear-
negative cases [2]. Early diagnosis of smear-negative pulmonary
TB in this group, if specific treatment is initiated quickly, has a
favorable impact on mortality [3,4]. However, this diagnosis
remains a major challenge for public health [5].
Sputum smear microscopy (SSM) is the main method used for
diagnosing pulmonary TB, especially in countries with limited
financial resources [6,7] although it fails to detect up to 50% of TB
cases in PLHIV [5]. While this method achieves high specificity,
sensitivity is not high, especially in the diagnosis of paucibacillary
or extra-pulmonary forms of the disease [8]. These findings are
frequent [9] and have been on the increase in PLHIV [10]. A
negative smear may lead to either a late or even a lack of diagnosis
[2,3]. Furthermore, performing a sputum culture requires the
necessary infrastructure, which is not always easily available in TB
high-burden countries and, depending on the method used, results
may take up to weeks to become available [8].
Pulmonary TB in HIV-infected adults may appears with a post-
primary or typical radiological pattern in the early stages of
infection or with an atypical or primary radiological pattern in
more advanced stages of HIV infection [11,12]. Immunocompro-
mised adults present a TB profile similar to that encountered in
children [13]. With children, sensitivity to sputum culture or
gastric lavage is low, 30–40%, due to both technical difficulties and
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the pathogenesis of the disease in this group. Paucibacillary
tuberculosis is more common in this age group [14,15].
Scoring systems constitute an alternative tool for the diagnosis of
pulmonary tuberculosis in situations where there is a negative
sputum smear test [16]. The purpose of such systems is to quantify
the probability of a particular event based on previously identified
criteria [17]. The Brazilian Ministry of Health has adopted a
scoring system for the diagnosis of childhood/adolescent, smear-
negative TB [18]. It uses clinical and radiological features and
tuberculin skin test reactivity, to which scores are assigned
arbitrarily. This scoring system was validated for children aged
under 15 years, undergoing either outpatient [14,19,20] or
inpatient investigation [14,21]. Because of the similarities in the
clinical and radiological presentations of TB in children and many
HIV-infected adults with TB, the purpose of the present study was
to assess, among TB suspects, the accuracy of this scoring system
for the diagnosis of smear-negative pulmonary TB in HIV-infected
adults, and also to assess the association between clinical,
radiological and immunological factors and the diagnosis of
tuberculosis within this group.
Methods
Ethics Statement
This study is part of the CSV Project 182/06 - Project for
clinical and epidemiological study of TB/HIV co-infection in
Recife, approved by the Ethics Committee of the Universidade
Federal de Pernambuco (registration SISNEP FR-067 159/CAAE
0004.1.172.106-05/register CEP/CCS/UFPE 254/05).
Study Design
The present study was composed of four stages. The first stage
corresponded to a Phase III validation study [22] of a scoring
system adapted for diagnosing pulmonary TB in HIV-infected
adults, with negative or unperformed smear tests [Adapted
Scoring System(ASS)]. All enrolled individuals were suspected of
having tuberculosis and the objective of the study was to evaluate
if, among suspects, the scoring system would distinguish those with
and without the target disorder (tuberculosis). Phase III studies
differ from Phase I and II studies because, in the latter, the
comparison is made between a group of patients who already have
a established diagnosis and normal individuals [22].
In the second stage of the study, a case-control analysis was
undertaken, in which cases were considered as those individuals
with pulmonary TB, and non-cases (controls) were pulmonary TB
suspects, but undiagnosed with TB. The association between
pulmonary TB and different groups of variables potentially
associated with the disease was assessed. This step aimed to
identify variables, which could be added to the scoring system. In
the third stage, the accuracy parameters for the model identified in
the previous stage [Modified Scoring System(MSS)] were calcu-
lated. The fourth stage proposed another scoring system [Scoring
System with New Scores(SSNS)]. To propose a scoring system
with new scores we used the values of the coefficients b estimated
in the final multivariate logistic model (following the example of
other authors [17,23,24] from the second stage. In the logistic
model these coefficients are obtained using the maximum
likelihood method and they represent the change in the log odds
that would result from a one unit change in one variable when all
others are fixed. The coefficient b of each variable was multiplied
by 10, in order to optimize the rounding off. Subsequently,
accuracy parameters were calculated. The analysis was repeated
limiting the total score to 15 to evaluate if there would be a if loss
of accuracy as such a simplified version, that could be easily used
without a calculator, could potentially increase the user-friendli-
ness and utilization/uptake of the scoring system in practice.
Study Population
Individuals aged over 18 years enrolled on a cohort of HIV-
infected adults from July 2007 to December 2010 and who were
pulmonary TB suspects. These individuals attended two referral
centers for HIV treatment in the state of Pernambuco, in the
Northeastern of Brazil. Pernambuco is the Brazilian state with the
second highest TB mortality rate (4.0 deaths per 100,000
inhabitants per year), almost double as compared to the national
rate [25]. The two referral centers serve approximately 70% of all
HIV cases in the state. Patients were monitored for a minimum
period of six months.
Definition of Terms and Study Variables
Individuals were considered pulmonary TB suspects if they
complained of cough (with or without sputum production) for any
length of time, and/or weight loss with a negative or unperformed
smear test. The choice of criteria was based on Cain et al. [26] and
Koole et al. [10] and on the WHO publication [8], which suggests
that cough alone for two weeks or more is an insensitive criterion
for the diagnosis of tuberculosis in PLHIV. An association of
symptoms is often necessary for such a diagnosis in this group but
the most appropriate combination remains unknown [8].
The main problem to evaluate a scoring system for diagnosing
tuberculosis in PLHIV is the choice of gold standard [1]. Although
a perfect gold standard is seldom available in diagnostic research,
this problem is particularly challenging when diagnosing tubercu-
losis in this group. In the absence of a perfect gold standard,
individuals in the present study were considered pulmonary TB
cases if (1) they presented a positive sputum culture for M.
tuberculosis or (2) had been notified as having pulmonary TB to the
Brazilian National System for Surveillance and Control of
Diseases (SINAN) or to the Mortality Information System (SIM)
during the 6-month period after the interview or even, (3) those
individuals without bacteriological confirmation, with clinical-
radiological improvement after treatment for TB was initiated by
the attending physician, in a follow-up period of no less than 6
months. All patients were followed-up for at least six months using
the information from medical records, SINAN and SIM. The
follow-up procedure was aimed at retrospectively assessing the
health status at time zero, instead of ascertaining the reference
standard of diagnosis for tuberculosis at time zero itself. The
scoring system tested was that recommended by the Brazilian
Ministry of Health for diagnosing childhood/adolescent TB [18],
adapted for HIV-infected adults with suspected smear-negative
pulmonary TB (ASS). The adapted criteria are presented in
Figure 1.
Factors potentially associated with pulmonary TB and analyzed
in the second, third and fourth stages will only be commented
upon should they call for any further clarification. The radiological
patterns were categorized as typical (cavitations or infiltrates in the
upper lobes of the lungs), atypical (pleural effusion, hilar or
mediastinal lymph nodes, diffuse or restricted infiltrates in the
lower lobes) and scars (fibrosis in the summits and upper lobes of
the lungs and calcified nodules). Alcohol consumption was
categorized as: abstainer/light drinker (has never drunk or drinks
two days per week, but not exceeding 10 drinks per month),
moderate drinker/heavy (drinks at least 3–4 days per week,
exceeding 5 drinks per day or undergoing treatment for
alcoholism). Smokers were categorized as: nonsmokers (those
who have never smoked during their lifetime), former smokers
(those who stopped smoking at least six months prior to study
Diagnosing Smear-Negative Pulmonary TB in HIV-Infected Adults
PLOS ONE | www.plosone.org 2 April 2014 | Volume 9 | Issue 4 | e95828
entry) and smokers (those who were smokers at the time of
enrollment or had stopped smoking during the six months prior to
study entry). The criteria used to define AIDS were those adopted
by the Brazilian Ministry of Health [27]. The drug use variable
was analyzed assessing each of the drugs independently (marijua-
na, cocaine, crack and glue). Antiretroviral therapy (ART) was
defined as a combination of three different antiretroviral drugs,
regardless of the number of drug classes used. The tuberculin test
(TT) was considered positive or reactive with a measurement of
induration $5 mm, according to the parameters defined for
PLHIV [18]. The CD4 variable was categorized as $200 cells/
mm3 and ,200 cells/mm3, as the latter reflects a greater
immunological impairment and is associated with increased
mortality in PLHIV [6,28].
Data Collection
Patients attending the two referral services were invited to
participate in the cohort. They were interviewed by previously-
trained health professionals, using standardized questionnaires,
after signing the informed consent. Additional information was
collected from medical records. Each patient was required to
undertake a chest X-ray, a blood count, a CD4 count and viral
load determination, TT, sputum microscopy and culture for
mycobacteria (for those who presented with sputum production) in
accordance with Brazilian Ministry of Health norms [18].
Brazilian Ministry of Health administration and reading tech-
niques were adopted for TT [18]. Radiologists from the above-
mentioned hospitals produced the radiology reports, according to
previously defined standards, with masking in relation to the
clinical suspicion of pulmonary tuberculosis. Individuals with
suspected pulmonary TB were included in the study.
Statistical Analysis
To analyze the accuracy of the ASS for the diagnosis of
tuberculosis in HIV-infected adults, a receiver operating charac-
teristic (ROC) curve was constructed and sensitivity (Se), specificity
(Sp), positive (PPV) and negative (NPV) predictive values, positive
Figure 1. Diagnosis of smear-negative pulmonary TB in children and adolescents adapted.* *scoring system for diagnosing smear-
negative pulmonary TB HIV-infected adults, adapted from the scoring system to diagnose smear-negative pulmonary TB in children and adolescent.
Source: Ministe´rio da Sau´de. Tuberculose. Guia de Vigilaˆncia Epidemiolo´gica, Brasil, 2002.
doi:10.1371/journal.pone.0095828.g001
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(LR+) and negative (LR2) likelihood ratios, with their respective
confidence intervals, were calculated.
For the second stage of the research, independent variables were
grouped into blocks: biological variables (gender, age); clinical
variables (fever, weight loss, coughing, sweating, asthenia, sputum
production, hemoptysis, chest pain, peripheral lymphadenopathy,
malnutrition (body mass index (BMI) ,18 kg/m2); variables
related to habits and lifestyle (smoking, drinking and illicit drugs
use); variables related to HIV (AIDS case, CD4 count, viral load,
ART); epidemiological variables (contact with TB, past TB);
variables related to diagnostic methods for TB (radiologic pattern,
which was defined as normal, typical or atypical and scar; TT
presented as reactive or non-reactive); history of cancer and use of
systemic corticosteroids.
The magnitude of association with the diagnosis of TB was
measured by odds ratio (OR) and statistical significance was tested
by the confidence interval (95%-CI) and p value (chi-square test or
maximum likelihood ratio). Significance level was set at p,0.05.
The multivariate logistic regression model was conducted in two
steps. In the first, all variables that comprised the ASS were
introduced into the model, and those with a p-value ,0.05 in
association with the outcome remained in the model. In the
second step, HIV-related variables that showed a p,0.25 in the
univariate analysis were introduced into the model, and those with
p,0.05 remained in the model.
In the third stage a score was given to the HIV-related variables
that remained in the multivariate model, and the accuracy
parameters of the MSS were calculated. In the fourth stage, so as
to create a scoring system with a new set of scores, the variables
that remained in the final multivariate regression model were
employed. By using the coefficient b derived from each
independent variable of the model, a score was attributed to each
variable, which was the coefficient b of each variable multiplied by
10, in order to optimize rounding off. The accuracy parameters of
the SSNS were calculated.
The population diagnosis attributed percent (PDA%) –the
fraction of diagnosis in the total study population attributable to a
factor – was estimated for multiple factors according to Bruzzi
et al. [29] for population attributable risks. Estimates were based
on the adjusted odds ratio and on the proportion of diseased
(tuberculosis) individuals presenting the factor under consider-
ation. Evaluating the relevance of the factor to the diagnosis is of
considerable assistance. It should be noted that when calculating
the ensemble of variables, the estimatation is not equivalent to
adding the PDA% to individual factors, because the approach
controls for confounding. [29].
Results
From a cohort of 2,382 HIV-infected adults, 1383 were
pulmonary TB suspects in accordance with the criteria defined
in the present study. Of these, 107 met the exclusion criteria
(Figure 2). Of the remaining 1276 individuals, 128 (10%) were
diagnosed with the pulmonary form of tuberculosis (5 presented an
association with the extra-pulmonary form, and 3 with the
disseminated form of the disease), during the period of the study.
Of the total number of studied individuals, 747 (58.6%) were
male and 201 (15.8%) were aged 30 years or less, 1039 (81.5%)
were aged between 30 and 59 years and 35 (2.7%) were 60 years
or over. Coughing was reported by 975 (76.5%) and weight loss by
664 (53.1%). Of those who had undergone a chest X-ray
(n = 1043, 82.6%), 186 presented a typical/atypical radiological
pattern and 129 a scar pattern, and of those who underwent the
TT (n = 548, 43%), 464 were non-reactive and 84 reactive. The
majority of patients were taking ART (n = 951, 74.8%) and 282
(26.6%) presented with CD4 counts ,200 cells/mm3.
Assessment of the ASS for HIV-infected adults through the
ROC curve indicated an area under the curve of 0.6960 (95%-CI
0.670–0.721) (Figure 3). An optimized diagnosis cut-off value $20
points was obtained (Table 1), with the following results:
Se = 60.9% (52.5%–69.4%), Sp = 64.7% (61.9%–67.5%),
PPV = 16.1% (12.9% –19.4%) and NPV = 93.7% (92% –95.4%),
LR+= 1.73 (1.5–2.0) and LR2= 0.60 (0.5–0.8). Variables that
presented a significant association with the diagnosis of pulmonary
TB in the univariate analysis were: - biological: male, - habits and
lifestyle: abstainer, - clinical: coughing, weight loss, presence of
sputum with or without blood, weight loss, fever, sweating,
asthenia, BMI ,18.5 kg/m2, lymphadenopathy; - related to
diagnostic methods for TB: typical, atypical or scar pattern chest
X-ray, reactive TT; - HIV-related: the absence of ART, CD4
count ,200 cells/mm3. No association was obtained between
cancer and use of systemic corticosteroids and the condition of the
TB cases. Variables that remained in the final multivariate model
are shown in Table 2.
For the MSS, which included CD4 count, the area under the
curve was 0.743 (95%CI-0.781–0.767) (Figure 3). The best cut-off
value was $30 points (Table 1), with the following parameters:
Se = 66.4% (57.5% –74.5%), Sp = 75.7% (73.1% –78.1%),
PPV = 23.4% (9.1% –28.0%) and NPV = 95.3% (93.7% –
96.6%), LR+= 2.73 (2.4–3.1) and LR2= 0.44 (0.3–0.6).
The assigned values in points, for each variable of the proposed
scoring system, together with the respective coefficients b are
detailed in Table 2. The area under the curve was for the SSNS
and was 0.8751 (95%-CI 0.8438–0.9063) (Figure 3). A better
diagnostic performance was registered for a cut-off value of 40
(Table 1), with Se = 81.2% (74.5% –88%), Sp = 78% (75.6% –
80.4%), PPV = 29.2% (24.5% –33.9%) and NPV = 97.4% (96.4%
–98.4%), LR+= 3.7 (3.4–4.0) and LR2= 0.24 (0.2–0.4).
The PDA% estimated for each variable in the final multivariate
model ranged from 6.5% to 66.0%, and the PDA% for a
combination of all factors was 68.2%.
The results of the simplified version, limiting the total score to
15 are presented in Tables 1 and 2. Table 1 shows the multivariate
analysis of the factors associated with the diagnosis of pulmonary
TB and the score assigned to each factor in the simplified version.
Table 2 compares the accuracy parameters of the SSNS according
to the cut-off values (with the optimized cut-off value marked in
‘‘bold-face’’), with those of the simplified version. A loss of
discriminatory power was observed.
Discussion
The scoring system of the Brazilian Ministry of Health for the
diagnosis of pulmonary TB in children and adolescents was
adapted by the authors of the present study for HIV-infected
adults (ASS), presenting with suspected smear-negative pulmonary
TB, and when tested, presented with a cut-off value of 20 points,
sensitivity of 60.9%, specificity of 64.7%, and LR+= 1.7 and
LR2= 0.6. The performance of the ASS in the study population
fell below that of the Brazilian Ministry of Health scoring system
with the population for which it was originally purposed. Studies
that used this score system for diagnosing TB in children and
adolescents reported sensitivity of 89% to 92% and specificity of
70% to 86% with 30 points [19,14], in agreement with the results
initially described when assessing the accuracy of the test [30]. In
the univariate analysis, all the variables that make part of the ASS
presented a statistically significant association with the diagnosis of
TB. However, contact with TB did not remain in the final
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multivariate model. This is probably due to the presence of other
variables that were associated with contact with TB, but that have
a closer association with the diagnosis.
In the present study there was an association between the
positive result of TT and the diagnosis of TB, although an
association was also found between the unperformed TT and the
diagnosis of TB. We have no explanation for this fact. It could be
that the clinical features of these patients are more suggestive of
TB or a more severe form of the disease, and the attending
physician initiated treatment earlier. Although recommended by
the Ministry of Health, the TT is not routinely used in these
circumstances.
The variables that remained in the final model had already been
considered in the Ministry scoring system except for the CD4
count ,200 cells/mm3. The CD4 count was proposed because it
is an important immunosuppression marker in HIV-infected
patients [31] and the choice of the cut-off value (,200) was due to
its association with more severe immune impairment [6].
Increased accuracy was observed when the CD4 count was
included in the system (MSS), and an additional increase with the
Figure 2. Algorithm of the selection of the study population to assess the accuracy of the scoring system in diagnosing smear-
negative pulmonary TB in HIV-infected adults in Pernambuco, Brazil, 2007–2010.
doi:10.1371/journal.pone.0095828.g002
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new proposed score (SSNS). Even with this increase, the
probability of the disease in a positive individual was still low,
around 29%. There was a high probability of an absence of disease
(97.4%) in an individual with a negative result.
Other studies have also used a scoring system as a diagnostic
tool for pulmonary TB in smear-negative TB suspects
[7,16,23,24,32]. Of these, several were retrospective (7,23,32),
thus constituting a limitation of these studies. Unlike the present
study, no other study assessed a population of exclusively HIV-
infected individuals. The measurements of accuracy varied
considerably amongst the studies: sensitivity 70% to 94%,
specificity 42% to 94%, PPV 43% to 73%, NPV 93% to 98.7%
in localities with a different prevalence of TB. The LR was
calculated and its usefulness discussed in a limited number of
studies, with reports of 3.85 for LR+ and 0.36 for LR2 in one
study [24] and of 7.1 for LR+ and 0.2 for LR2 in another [23].
However in the second study, the difference in the frequency of
tuberculin testing between cases and controls, a variable strongly
associated to diagnosing TB, may have caused selection bias and
therefore, interfered with the encountered accuracy.
The accuracy of the proposed SSNS is similar to those observed
in other studies, which used the same measurements, with the
exception of Kanaya et al [23]. The population diagnosis
attributed percent indicates that the studied factors explain
approximately 68.2% of all diagnoses. The higher figure obtained
for clinical symptoms highlights the importance of this subgroup of
variables compared to those related to diagnostic methods for TB
and CD4 counts.
The literature describes other types of instruments for diagnos-
ing smear-negative TB in HIV-infected patients. The proposed
diagnostic algorithm, updated by WHO [33], was recently
assessed by several studies with different measures of accuracy:
Koole et al [10](Se = 58.8%, Sp = 79.4%, PPV = 22.2% and
NPV = 95.1%), Wilson et al [34] (Se = 80%, Sp = 44%,
PPV = 34%, NPV = 86%, LR+= 1.43 and LR2= 0.46), and
Walley et al [2] (Se = 96%, Sp = 98%, PPV = 93% and
NPV = 99%). This latter study with improved accuracy, notes
however that only 13% of the studied population completed all the
elements of the algorithm, which is one significant limitation. In
other studies, algorithms or a combination of clinical features,
supplemented with chest X-rays and a CD4 counts were proposed
[5,26,35]. The results of which varied from no association with the
diagnosis of TB [35] to a greater variation in the measurements of
sensitivity (64.5%–93%) specificity (35%–64%), and PPV (9.9%–
24%), but not in the NPV (95%–97%) [5,32]. Only one study
included and discussed the LR calculations, with an interval of
1.44–1.76 for LR+ and of 0.18–0.27 for LR2 [26]. Getahun et al
[1], in a meta-analysis investigating TB in PLHIV, with no
discrimination of the smear, proposed an investigation system with
the presence of any 1 of 4 specific clinical criteria for investigating
TB with Se = 78.9%, Sp = 49.6%, NPV = 95.3% for the combi-
nation. With the exception of Walley et al [2], the above-cited
studies presented a diagnostic accuracy similar to that observed in
the present study, in relation to the presented measurements of
accuracy. The abovementioned studies indicate a great variation
in accuracy measurements indicating that the diagnosis of smear-
Figure 3. Comparison of ROC curves for the Adapted Scoring System (ASS), Modified Scoring System (MSS) and Scoring System
with New Scores (SSNS) for the diagnosis of smear-negative pulmonary TB in HIV-infected adults.
doi:10.1371/journal.pone.0095828.g003
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negative pulmonary TB in PLHIV remains an enormous
diagnostic challenge, especially when diagnostic resources are
limited.
The present study presents a number of limitations. One of
them is how to define a case of TB, without bacteriological
confirmation in most cases, using clinical and radiological
improvement criteria after initiating treatment for TB. In the
absence of a perfect gold standard the present study used a
reference standard that would approximate the gold standard [36].
Furthermore, this criterion was also used in other studies that
applied the scoring system [19,20] as well as in a study with
another scoring system [32]. The difficulty of obtaining material
for bacteriological confirmation, delayed culture results and the
impossibility of adopting more expensive, complex diagnostic
methods, justify the use the therapeutic response as criteria for
defining TB. The range of the scoring system proposed makes it
more difficult to be used without a calculator. However the
analysis of the simplified version, limiting the total score to 15,
showed a loss of discriminatory power. One further limitation is
related to the fact that the results encountered maybe be only valid
for the population studied. As the discriminatory power of the
point scoring system may vary across settings, due to differences in
the frequency of co-infection and due to the variability of signs and
symptoms among patients, it would be advisable to replicate this
Phase III study, applying the SSNS to HIV-infected adults in
different settings with different epidemiological scenarios.
Nevertheless, this study has some methodological strengths.
This was a prospective study, thus minimizing information bias.
Participants were both outpatients and inpatients, therefore
avoiding the selection of individuals with a given potential of
severity. All patients were followed up for a minimum period of six
months in order to reduce the misclassification of cases and non-
cases of TB. All subjects were HIV-positive, a fact not observed in
other studies involving scoring systems.
Table 2. Multivariate analysis of the factors associated to the diagnosis of pulmonary TB, and the scoring for each variable, in HIV-
infected adults and suspected smear-negative pulmonary TB, in Pernambuco, Brazil, 2007–2010.
Variables OR (95%-CI) p-value b New score* % PDA%***
Model 68.2
Clinical Symptoms 88.4
Cough**
No 1.0 – 0 points
Yes 3.96 (1.95–8.05) 0.000 1.38 14 points 66.0
Weight loss
No 1.0 – 0 points
Yes 2.44 (1.43–4.15) 0.001 0.89 9 points 43.9
Fever
No 1.0 – 0 points
Yes 1.99 (1.22–3.23) 0.005 0.69 7 points 25.3
Malnutrition
No 1.0 – 0 points
Yes 2.62 (1.51–4.54) 0.001 0.96 10 points 18.6
Related to diagnostic methods for TB 62.0
Radiological pattern
Normal 1.0 – – 0 points
Typical/Atypical 9.14 (5.33–15.7) 0.000 2.21 22 points
Scar 2.81 (1.32–5.96) 0.007 1.03 10 points 59.4
No X-ray 0.93 (0.43–2.01) 0.851 –
Tuberculin test
Non-reactor 1.0 – – 0 points
Reactor 4.03 (1.63–9.98) 0.003 1.39 14 points 6.5
Not undertaken 2.64 (1.49–4.70) 0.001 0.97 10 points
Related to HIV 42.1
CD4 T cell count
$200 1.0 – –
,200 3.19 (1.82–5.57) 0.000{ 1.16 12 points 42.1
*To optimize the rounding off of the score, the regression scores were multiplied by 10.
**For people living with HIV and suspected smear-negative pulmonary TB, whose criteria on entering the study was weight loss.
*** Population diagnosis attributed percent - percent of diagnosis attributed to a factor or group of factors.
Sample size 1276 individuals.
doi:10.1371/journal.pone.0095828.t002
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Conclusion
The accuracy of the Brazilian Ministry of Health scoring system
when used for diagnosing smear-negative TB in HIV-infected
adults limits its use in clinical practice. In the studied population,
the new scoring system presented a similar accuracy to other
instruments tested, and a good capacity for distinguishing patients
without pulmonary TB. Further studies should apply this new
scoring system in order to validate it, thus assessing its use in
diagnosing pulmonary smear-negative TB in HIV-infected adults.
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